Who
Peter O'Rourke
Director
Company insider
Files Form 4 as: Director, Quantum Cyber; Director, Profusa; Director, Axim Biotechnologies.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 15 Mar 2024
- Last trade
- 31 Jul 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,840 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,840 at $0.00 | filing |
| 22 Jul 2026filed 6 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code A | —191,860 at $0.00 | filing |
| 22 Jul 2026filed 6 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code A | —191,860 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,859 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,859 at $0.00 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —107,750 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code J | —15,250 at $0.00 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code J | —15,250 at $0.00 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —107,750 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | Axim Biotechnologiesoption or derivative | SEC FORM 4 Code A | $1.2B35,000 at $35,000.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.